SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing intense trading activity driven by strong community conviction in its QNX software platform and physical AI narrative, alongside momentum from a potential major European design win. Investors are actively discussing the stock's transition from a legacy name to a growth play, dismissing recent pullbacks as healthy consolidation while largely ignoring bearish calls from short sellers.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is seeing significant pre-earnings momentum as investors speculate on its role in AI infrastructure, with community discussions split between bullish excitement over potential 'beat-and-raise' results and cautious concerns about high valuations. The stock is currently trending due to intense options activity and anticipation of its upcoming earnings report, which many traders hope will mirror the explosive post-earnings performance seen in other AI-related semiconductor peers.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is facing downward pressure following a high-profile rocket test failure by Blue Origin, which has sparked investor concerns over potential delays to the company's Project Kuiper satellite constellation. Meanwhile, the community is deeply divided between long-term bulls who view the dip as an attractive entry point for a diversified AI and cloud powerhouse, and skeptics who are increasingly focused on the capital-intensive nature of big tech's AI infrastructure spending.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is experiencing a parabolic surge driven by aggressive momentum trading following comments from the CEO of NVIDIA, who highlighted its potential as a trillion-dollar company. Community sentiment is deeply polarized, with many bulls chasing the rapid gains based on institutional backing and AI infrastructure growth, while vocal skeptics argue the move is a disconnected pump-and-dump that lacks fundamental support.

Galaxy Digital, Inc. engages in digital assets and data center infrastructure, delivering solutions that accelerate progress in finance and artificial intelligence. It operates through the following segments: Digital Assets, Data Centers, and Treasury and Corporate. The digital assets segment offers institutional access to trading, advisory, asset management, staking, self-custody, and tokenization technology. The Data Centers segment competes with a range of infrastructure providers that are building or repurposing facilities to support the rapidly growing demand for AI and compute-intensive workloads. The Treasury and Corporate segment includes the company’s proprietary trading and mining activities, as well as the company’s principal investments and related gains and losses. The company was founded by Michael Novogratz in 2018 and is headquartered in New York, NY.

Galaxy Digital Inc. - Ordinary Shares - Class A

Galaxy Digital is facing intense community frustration due to its persistent underperformance relative to other data center stocks, with shareholders actively calling for leadership changes and the separation of its crypto and infrastructure business units. While some investors remain hopeful that the company's Helios power assets will eventually decouple the stock's price from Bitcoin volatility, current sentiment is dominated by disappointment over a perceived lack of meaningful communication and delayed acquisition news.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is experiencing intense volatility as investors debate the impact of heavy AI-related capital expenditures following the company's annual developer conference. The community remains sharply divided, with bulls viewing the pullback as a buying opportunity for a long-term AI leader while bears point to growing antitrust concerns and skepticism regarding the immediate profitability of recent hardware and quantum announcements.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is seeing significant market activity driven by the U.S. Department of Energy's selection of the company for advanced negotiations to use surplus Cold War-era plutonium as reactor fuel. The community is actively debating the stock's future, weighing institutional bullishness from major analyst upgrades and long-term partnerships against concerns regarding pre-revenue status, potential dilution, and the long-term feasibility of micro-reactor deployment.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is surging as investors react to robust revenue growth and an increased sales outlook for Briumvi, which reinforces its competitive position in the MS market. The community is actively debating the potential for a multibillion-dollar buyout, with many highlighting upcoming clinical data readouts as key catalysts that could drive further valuation gains.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as it captures investor attention for its role in the 800V AI data center power architecture, further catalyzed by its inclusion in Nvidia's MGX ecosystem. The community remains intensely divided between bulls focused on the potential for massive infrastructure scaling and bears citing valuation concerns and significant insider share selling.

CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011 and is headquartered in Austin, TX.

Crowdstrike Holdings Inc - Ordinary Shares - Class A

Crowdstrike Holdings Inc

CrowdStrike is seeing massive institutional buying and price appreciation, fueled by a broader rotation into cybersecurity stocks and heightened enterprise demand for AI-driven threat detection. Investors are actively debating whether this parabolic move is a sustainable re-rating of the security sector or an overextended bubble, while keeping a close eye on upcoming earnings for further momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Is Amneal Pharmaceuticals (AMRX) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Is it a Good Idea to Invest in Amneal Pharmaceuticals Stock Now?

AMRX is building momentum with growth across specialty drugs and biosimilars, supported by new launches and a diversified portfolio.

Why Amneal Pharmaceuticals (AMRX) is a Top Growth Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

3 Reasons Why Growth Investors Shouldn't Overlook Amneal (AMRX)

Amneal (AMRX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Should Value Investors Buy Amneal Pharmaceuticals (AMRX) Stock?

Amneal (AMRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Revised)

Although the revenue and EPS for Amneal (AMRX) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Do Options Traders Know Something About Amneal Stock We Don't?

Investors need to pay close attention to AMRX stock based on the movements in the options market lately.

Artemis Investment Management LLP Buys Shares of 124,899 Amneal Pharmaceuticals, Inc. $AMRX

Artemis Investment Management LLP bought a new stake in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 124,899 shares of the company's stock, valued at approximately $1...

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Short Interest Update

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) was the target of a large increase in short interest in the month of April. As of April 15th, there was short interest totaling 8,556,479...

Is Amneal (AMRX) a Solid Growth Stock? 3 Reasons to Think "Yes"

Amneal Pharmaceuticals, Inc. is a medicine company, which engages in the provision of pharmaceuticals. Its product portfolio includes generics, specialty, biosciences, and product catalog. It operates through the following segments: Generics, Specialty, and AvKARE. The Generics segment relates to oral solids, powders, liquids, sterile injectables, nasal sprays, inhalation and respiratory products, biosimilar products, ophthalmics, films, and transdermal patches and topicals. The Specialty segment refers to the development, promotion, sale, and distribution of proprietary branded pharmaceutical products. The AvKARE segment provides pharmaceuticals, medical, and surgical products and services to governmental agencies. The company was founded by Chirag K. Patel and Chintu Patel in 2002 and is headquartered in Bridgewater, NJ.

AMRXAmneal Pharmaceuticals Inc - Ordinary Shares - Class A

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AMRX News